Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-08
2005-02-08
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S326000, C514S340000, C514S364000, C544S138000, C546S209000, C546S269100, C548S131000
Reexamination Certificate
active
06852719
ABSTRACT:
The present invention provides non-steroidal compounds of Formula I, including prodrugs and pharmaceutically acceptable salts thereof, which are selective modulators (e.g., agonists, partial agonists and antagonists) of a steroid receptor, specifically, the glucocorticoid receptor. The present invention also provides pharmaceutical compositions containing these compounds and methods for using these compounds to treat animals requiring glucocorticoid receptor agonist or antagonist therapy. Glucocorticoid receptor modulators are useful to treat diseases, such as obesity, diabetes, inflammation and others as described below. The present invention also provides processes for preparing these compounds
REFERENCES:
patent: 3683091 (1972-08-01), Nagata et al.
patent: 5696127 (1997-12-01), Jones et al.
patent: 5767113 (1998-06-01), Cohn et al.
patent: 6380223 (2002-04-01), Dow et al.
patent: 6699893 (2004-03-01), Dow et al.
patent: 0188396 (1986-07-01), None
patent: 0683172 (1997-08-01), None
patent: 0903146 (1999-03-01), None
patent: 4514056 (1970-05-01), None
patent: 4536500 (1970-11-01), None
patent: 50111098 (1975-09-01), None
patent: 6263688 (1994-09-01), None
patent: 9052899 (1997-02-01), None
patent: WO 9510266 (1995-04-01), None
patent: WO 9826783 (1998-06-01), None
patent: WO 9827986 (1998-07-01), None
patent: WO 9831702 (1998-07-01), None
patent: WO 9933786 (1999-07-01), None
patent: WO 9941256 (1999-08-01), None
patent: WO 9941257 (1999-08-01), None
patent: WO 9963976 (1999-12-01), None
patent: WO 0006137 (2000-02-01), None
patent: WO 0007972 (2000-02-01), None
patent: WO 0066522 (2000-11-01), None
patent: 6706757 (1967-11-01), None
C.F. Bigge et al., J. Med. Chem., 1993, 36, 1977-1995, “Synthesis and Pharmacological Evaluation of 4a-Phenanthrenamine Derivatives Acting at the Phencyclidine Binding Site of the N-Methyl-D-aspartate Receptor Complex”.
P. R. Kanjilal et al., J. Org. Chem., 1985, 50, 857-863, “Synthetic Studies toward Complex Diterpenoids. 16.1A Novel Synthetic Route to the Carbocyclic Skeleta of Stemodin and Stemarin by Acid-Catalyzed Intramolecular C-Alkylation and Rearrangement Reactions”.
G. Sinha et al., J. Chem. Soc., Perkin Trans. I (1983), (10), 2519-2528, “Condensed Cyclic and Bridged-ring System. Part 9.1Stereocontrolled Synthesis and X-Ray Structural Analyses of cis-3,4,4a,9,10,10a-Hexahydro-1,4a-ethanophenanthrene-2-(1H), 12-dione and trans-3,4,4a,9,10,10a-Hexahydro-3,4-ethanophenanthrene-2(1H), 12-dione”.
U. R. Ghatak et al., Tetrahedron Letters No. 32, pp. 2929-2932, 1978, “Angular Alkylation Through a Novel Intramolecular Cationic Reaction. A Simple Stereospecific Route to Polycyclic Bridged-Ring Intermediates Towards Some Complex Diterpenoids”.
P. N. Chakrabortty et al., Indian J. Chem. (1974), 12(9), 948-55, “Synthetic Studies in Resin Acid Series: Part VII—Synthesis of 1α-Methyl-1β,4aβ-dicarboxy-1,2,3,4,4a,9,10,10aβ-octahydrophenanthrene & 1β,4aβ-Dicarboxy-1,2,3,4,4a,9,10,10aα-octahydrophenanthrene”.
E. Fujita et al., J. Chem. Soc., Perkin Trans. I (1974), (1), 165-77, “Terpenoids. Part XXVIII.1Total Synthesis of Enmein2”.
H. Sdassi et al., Synthetic Communications, 25(17), 2569-2573 (1995), “Enantioselective Synthesis of (R)-(+)-4a-Cyanomethyl-6-Methoxy-3,4,9,10-Tetrahydrophenanthren-2-one”.
T. Ibuka et al., Yakugaku Zasshi (1967), 87(8), 1014-17, “Studies on the Alkaloids of Menispermaceous Plants. CCXXXVI.3”(and English language translation).
D. Bonnet-Delpon et al., Tetrahedron (1996), 52(1), 59-70, “Trifluoromethylalkenes in Cycloaddition Reactions#”.
J. A. Findlay et al., Tetrahedron Letters No. 19, pp. 869-872, 1962, “Synthesis in the Diterpene Alkaloid Series—I—The Stereospecific Synthesis of an Intermediate and its Identification With a Natural Degradation Product”.
Liu Kevin K.
Morgan Bradley P.
Robinson Ralph P.
Pfizer Inc.
Pfizer Products Inc.
Scully Scott Murphy & Presser
Stockton Laura L.
LandOfFree
Glucocorticoid receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucocorticoid receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucocorticoid receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3472740